Linder N, Yaron M, Handsher R, Kuint J, Birenbaum E, Mazkereth R, Lubin D, Mendelson E, Safrir O, Reichman B
Department of Neonatology, Tel Aviv University, Kfar Saba, Israel.
J Pediatr. 1995 Jul;127(1):128-30. doi: 10.1016/s0022-3476(95)70272-5.
The antibody titers of 41 premature infants receiving inactivated poliovirus vaccine at 2 months of age (control group) were compared with titers of 39 infants receiving an additional dose at 5 to 10 days of age (study group). At 1 month of age 97.4% of the study group but only 70.8% of the control group had protective antibodies against poliovirus 3 (p < 0.001).
将41名2月龄接受灭活脊髓灰质炎疫苗的早产儿(对照组)的抗体滴度与39名在5至10日龄额外接种一剂疫苗的婴儿(研究组)的抗体滴度进行比较。1月龄时,研究组97.4%的婴儿具有针对脊髓灰质炎病毒3型的保护性抗体,而对照组只有70.8%(p<0.001)。